# China Life Private Equity Investment

> China Life Private Equity Investment is a VC fund backing Biotechnology. See 36 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 36
- Last investment: Jul 2026
- Lead investor: 53%
- Last updated: Aug 2026
- Website: https://www.chinalifepe.com/

China Life Private Equity Investment is a equity investment platform.

## Contacts

5 contacts available for China Life Private Equity Investment. Shizune tracks 1 team members at China Life Private Equity Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/china-life-private-equity-investment?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $29M–$142M |
| Series B | $42M–$718M |
| Series C | $4.3M–$283M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 10 | 28% |
| Health Care | 8 | 22% |
| Biopharma | 7 | 19% |
| Manufacturing | 6 | 17% |
| Pharmaceutical | 6 | 17% |

34 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 11 | 31% |
| Series B | 7 | 19% |
| Series A | 3 | 8% |
| Series D | 3 | 8% |
| Funding Round | 2 | 6% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 22 | 61% |
| United States | 2 | 6% |
| Japan | 1 | 3% |
| Malaysia | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Wan Yiqing | President | 1 | https://shizune.co/investors/profile/wan-yiqing |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NNB Nutrition | NNB Nutrition is a technology company devoted to the study, creation, manufacture, and marketing of novel nutritious raw materials. They  processing mode to develop and produce innovative raw materials for international partners. NNB consistently focuses on using technical innovation as its core productivity, fully assuring product quality, anddevoting itself to developing components for human health in today's thriving health business. | $29.5M | Series C | Jul 13, 2026 |  |
| Sudu Technology | Sudu Technology is a high-tech enterprise specializing in the research and development of general-purpose robot brains, focusing on building advanced cognitive architectures that integrate perception, decision-making, and control, enabling robots to operate autonomously across diverse environments and tasks while continuously learning and adaptingthrough real-world interactions. |  | Series A | Apr 20, 2026 |  |
| Xellar Biosystems | Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $29M | Series A | Apr 02, 2026 |  |
| StepFun | The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like | $718.1M | Series B | Jan 26, 2026 |  |
| Chaoqun Testing Technology | Chaoqun Testing Technology is an X-ray equipment manufacturer that focuses on the design and manufacturing of industrial and medical X-ray tubes, sources, and systems. | $70.2M | Venture - Series Unknown | Oct 24, 2025 |  |
| SJ Semi | SJ Semi is a MEOL (Middle-End of Line) foundry which implements front-end wafer manufacturing and quality systems to MEOL operations. SJSemi's main business is providing bumping, Cu pillar, RDL, and testing services for 12" wafers. The company also places heavy R&D emphasis on fan-out, TSV, interposer, and 3D technologies. | $700M | Venture - Series Unknown | Dec 31, 2024 |  |
| Autolink | Autolink is a vehicle intelligent terminal solution provider. |  | Series D | May 24, 2024 |  |
| Xindi Digital Engineering System | Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises. |  | Series D | Jan 25, 2024 |  |
| Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals. | $63.4M | Series C | Jan 02, 2024 |  |
| Astronergy | Astronergy specializes in cutting-edge research, development and production of solar modules. It is the first large scale producer of high-efficiency thin film PV modules in mainland China, and has been a trusted provider of monocrystalline and polycrystalline PV modules since its founding in 2006. | $283.5M | Series C | Jul 25, 2023 |  |

10 of 36 investments shown.

## Co-investors
- [Xinshang Capital](https://shizune.co/investors/profile/xinshang-capital) — VC Fund, 5 deals together
- [GF Qianhe Investment](https://shizune.co/investors/profile/gf-qianhe-investment) — VC Fund, 4 deals together
- [PICC Capital Investment Management](https://shizune.co/investors/profile/picc-capital-investment-management) — VC Fund, 4 deals together
- [SDIC Venture Capital](https://shizune.co/investors/profile/sdic-venture-capital) — VC Fund, 4 deals together
- [Biocytogen](https://shizune.co/investors/profile/biocytogen) — VC Fund, 2 deals together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Biotech VC Funds in Malaysia](https://shizune.co/investors/biotech-vc-funds-malaysia)

## FAQ

### What does China Life Private Equity Investment invest in?

China Life Private Equity Investment invests primarily in Biotechnology, Health Care and Biopharma startups, most often at Series C and Series B stage. Most of the 36 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is China Life Private Equity Investment's check size?

China Life Private Equity Investment typically joins rounds of $29M–$142M at Series A, $42M–$718M at Series B and $4.3M–$283M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds China Life Private Equity Investment participates in.

### How do I contact China Life Private Equity Investment?

Public channels for China Life Private Equity Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at China Life Private Equity Investment?

The team at China Life Private Equity Investment includes Wan Yiqing (President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co